<unk>  is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90percent of glucose reabsorption into the blood. Blocking SGLT-2 reduces blood glucose by blocking glucose reabsorption in the kidney and thereby excreting glucose (i.e., blood sugar) via the urine.
Empagliflozin
Canagliflozin
Linagliptin
Dapagliflozin
Sotagliflozin
Liraglutide
Vildagliptin
Pioglitazone